<DOC>
	<DOCNO>NCT01452958</DOCNO>
	<brief_summary>Main objective : The purpose study prove effect bacterial endotoxin cytokine TNF-α , protein loss , fatty acid release , glucose metabolism depend two mechanism : 1 . Direct local effect muscle tissue . 2 . Activation hypothalamo-pituitary axis stress-hormone response Study protocols : 1 . Acute metabolic effect TNF-α ( Beromun , Boehringer-Ingelheim Germany ) v placebo perfuse femoral artery leg 8 healthy subject . 2 . Acute metabolic effect - placebo ( saline ) - endotoxin ( US standard reference E.Coli , endotoxin ) - TNF-α ( Beromun , Boehringer-Ingelheim Germany ) give systemically - 8 patient hypopituitarism ( block stress hormone release ) 8 healthy subject study thrice .</brief_summary>
	<brief_title>Endotoxin &amp; Cytokines . Do Protein Loss Metabolic Effects Depend Central Nervous System ( CNS ) Activation Stress Hormones Local Mechanisms Muscle Fat ?</brief_title>
	<detailed_description>PURPOSE : Knowledge effect bacterial endotoxin cytokine ( inflammation general ) humans protein , glucose lipid metabolism intracellular signal muscle fat sporadic uncertain whether endotoxin cytokine act directly fat muscle tissue indirectly via central nervous system ( CNS ) mediate stress hormone release . The investigator hypothesize metabolic effect endotoxin cytokine TNF-α , include protein loss , fatty acid release decrease glucose uptake depend two mechanism : 1 . Direct local effect muscle tissue ( Study protocol 1 ) 2 . Activation hypothalamo-pituitary axis generalize stress hormone response ( Study protocol 2 ) METHODOLOGY : Study protocol 1 : Acute metabolic effect TNF-α ( Beromun , Boehringer-Ingelheim , Germany ) versus placebo perfuse femoral artery leg 8 healthy subject , study . Femoral vein sample allows assessment local metabolic event leg . The vessel cannulate use Seldinger technique . Each study comprise 3 hour basal period 3 hour Hyperinsulinemic-Euglycemic Clamp . Muscle biopsy obtain simultaneously lateral vastus muscle . Study protocol 2 : Acute metabolic effect ( ) placebo ( saline ) , ( ii ) endotoxin ( US standard reference E.Coli , endotoxin ) ( iii ) TNF-α ( Beromun , Boehringer-Ingelheim , Germany ) give systemically intravenously ( i.v . ) 8 patient hypopituitarism ( block stress hormone release ) 8 healthy subject study thrice . Every study comprise 4 hour basal period 2 hour Hyperinsulinemic-Euglycemic Clamp . Muscle fat biopsy obtain . Study protocol 1 Study protocol 2 : Assays : Mass spectrometry ( 15N-phenylalanine , 13C-urea ) , 3H-glucose , 3H-palmitate quantification , hormone metabolite analysis , cytokine assay , intracellular signaling .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Glucose Metabolism Disorders</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Inclusion Criteria 1. group : Male 19 &lt; BMI &lt; 28 18 ≤ Age ≤ 50 Healthy Inclusion Criteria 2. group : Male 20 &lt; BMI &lt; 30 Age &gt; 25 Healthy Diseases Allergy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Endotoxin</keyword>
	<keyword>LPS</keyword>
	<keyword>TNF-α</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>metabolism</keyword>
</DOC>